Paper36944680
Cellular mechanisms of heterogeneity in NF2-mutant schwannoma.
Chiasson-MacKenzie C and 7 others. Nat Commun, 2023. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. Cellular mechanisms of heterogeneity in NF2-mutant schwannoma. Papers, record 36944680. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36944680
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, N.I.H., Extramural
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neurofibromatosis 2 | Major topic |
| Neurilemmoma | Major topic |
| Animals | |
| Mice | |
| Humans | |
| Neurofibromin 2 | |
| Mutation | |
| Schwann Cells | |
| Genes, Tumor Suppressor |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA226871 | NCI NIH HHS | United States | R01CA226871 | PubMed | NIH RePORTER |
| S10 OD025017 | NIH HHS | United States | S10OD025017 | PubMed and NIH | NIH RePORTER |
References83
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27273766 | YAP and TAZ control peripheral myelination and the expression of laminin receptors in Schwann cells. | Nat Neurosci | 2016 | https://conductscience.org/library/papers/27273766 | PubMed |
| 2 | 22426462 | Regulation of mTOR complex 2 signaling in neurofibromatosis 2-deficient target cell types. | Mol Cancer Res | 2012 | https://conductscience.org/library/papers/22426462 | PubMed |
| 3 | 25113746 | A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation. | Hum Mol Genet | 2015 | https://conductscience.org/library/papers/25113746 | PubMed |
| 4 | 22516196 | Growth control by committee: intercellular junctions, cell polarity, and the cytoskeleton regulate Hippo signaling. | Dev Cell | 2012 | https://conductscience.org/library/papers/22516196 | PubMed |
| 5 | 24687281 | Functionally distinct PI 3-kinase pathways regulate myelination in the peripheral nervous system. | J Cell Biol | 2014 | https://conductscience.org/library/papers/24687281 | PubMed |
| 6 | 35580586 | mTOR substrate phosphorylation in growth control. | Cell | 2022 | https://conductscience.org/library/papers/35580586 | PubMed |
| 7 | 27655473 | Neurofibromatosis Type 2. | J Child Neurol | 2017 | https://conductscience.org/library/papers/27655473 | PubMed |
| 8 | 23249734 | Merlin/ERM proteins establish cortical asymmetry and centrosome position. | Genes Dev | 2012 | https://conductscience.org/library/papers/23249734 | PubMed |
| 9 | 30143526 | Merlin/ERM proteins regulate growth factor-induced macropinocytosis and receptor recycling by organizing the plasma membrane:cytoskeleton interface. | Genes Dev | 2018 | https://conductscience.org/library/papers/30143526 | PubMed |
| 10 | 16341207 | The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis. | Nat Cell Biol | 2006 | https://conductscience.org/library/papers/16341207 | PubMed |
| 11 | 17893219 | Neuropathology for the neuroradiologist: Antoni A and Antoni B tissue patterns. | AJNR Am J Neuroradiol | 2007 | https://conductscience.org/library/papers/17893219 | PubMed |
| 12 | 32404937 | Chemotaxing neutrophils enter alternate branches at capillary bifurcations. | Nat Commun | 2020 | https://conductscience.org/library/papers/32404937 | PubMed |
| 13 | 21182951 | Schwannomin/merlin promotes Schwann cell elongation and influences myelin segment length. | Mol Cell Neurosci | 2011 | https://conductscience.org/library/papers/21182951 | PubMed |
| 14 | 32547370 | Metabolic Interaction Between Schwann Cells and Axons Under Physiological and Disease Conditions. | Front Cell Neurosci | 2020 | https://conductscience.org/library/papers/32547370 | PubMed |
| 15 | 27672367 | Macropinocytosis Exploitation by Cancers and Cancer Therapeutics. | Front Physiol | 2016 | https://conductscience.org/library/papers/27672367 | PubMed |
| 16 | 25706233 | A molecular mechanotransduction pathway regulates collective migration of epithelial cells. | Nat Cell Biol | 2015 | https://conductscience.org/library/papers/25706233 | PubMed |
| 17 | 20511180 | ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma. | Neuro Oncol | 2010 | https://conductscience.org/library/papers/20511180 | PubMed |
| 18 | 20832498 | Nrg1/ErbB signaling networks in Schwann cell development and myelination. | Semin Cell Dev Biol | 2010 | https://conductscience.org/library/papers/20832498 | PubMed |
| 19 | 24311643 | Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas. | Neuro Oncol | 2014 | https://conductscience.org/library/papers/24311643 | PubMed |
| 20 | 26928656 | Extracellular vesicles for drug delivery. | Adv Drug Deliv Rev | 2016 | https://conductscience.org/library/papers/26928656 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42764387 | Advancing neurofibromatosis research: a comparative review of animal models and their utility in dissecting the tumor microenvironment. | Lab Anim Res | 2026 | https://conductscience.org/library/papers/42764387 | PubMed |
| 42662719 | NF2 lacking exon 11 induced by antisense gene therapy is able to partially recover merlin deficiency in NF2-SWN iPSC-derived spheroid model. | Mol Ther Nucleic Acids | 2026 | https://conductscience.org/library/papers/42662719 | PubMed |
| 42143176 | Vestibular schwannoma: genetic and epigenetic mechanisms, hearing loss, and emerging therapies. | J Neurooncol | 2026 | https://conductscience.org/library/papers/42143176 | PubMed |
| 42035704 | Data-driven thresholds for standardized classification of severe Alzheimer's disease neuropathology using digital neuropathology. | Brain Pathol | 2026 | https://conductscience.org/library/papers/42035704 | PubMed |
| 42034799 | Loss of meningothelial identity and mesenchymal fate switching in NF2-mutant meningiomas. | Acta Neuropathol | 2026 | https://conductscience.org/library/papers/42034799 | PubMed |
| 41988151 | Endoscopic-assisted low-temperature plasma resection of tongue root schwannoma via oral approach: a case report and literature review. | Front Pediatr | 2026 | https://conductscience.org/library/papers/41988151 | PubMed |
| 41929036 | Quantitative imaging of schwannoma captures heterogeneity and accelerates preclinical testing, revealing distinct impacts of targeted therapies. | bioRxiv | 2026 | https://conductscience.org/library/papers/41929036 | PubMed |
| 41898726 | Emerging Molecular Insights and Therapeutic Directions in Neurofibromatosis Type 1 and NF2-Related Schwannomatosis. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41898726 | PubMed |
| 41461563 | In vivo screen reveals specific roles of Hippo pathway components in development and regeneration. | Life Sci Alliance | 2026 | https://conductscience.org/library/papers/41461563 | PubMed |
| 41293003 | Variable Schwann cell merlin inactivation is targetable with TEAD1 inhibition in schwannomas. | bioRxiv | 2025 | https://conductscience.org/library/papers/41293003 | PubMed |
| 41001135 | Schwann cells in the inner ear: development, disease, and regeneration. | Front Cell Neurosci | 2025 | https://conductscience.org/library/papers/41001135 | PubMed |
| 40940747 | Pathologic and Therapeutic Schwann Cells. | Cells | 2025 | https://conductscience.org/library/papers/40940747 | PubMed |
| 40895102 | Investigating cochlear cellular dynamics in neurofibromatosis type 2-associated schwannomatosis: a histopathological study. | Front Neurol | 2025 | https://conductscience.org/library/papers/40895102 | PubMed |
| 40746735 | iPSC-based merlin-deficient Schwann cell-like spheroids as an in vitro system for studying NF2 pathogenesis. | Genes Dis | 2025 | https://conductscience.org/library/papers/40746735 | PubMed |
| 40343504 | Multiplatform molecular analyses reveal two molecular subgroups of NF2-related schwannomatosis vestibular schwannomas with distinct tumour microenvironment and therapeutic vulnerabilities. | Acta Neuropathol | 2025 | https://conductscience.org/library/papers/40343504 | PubMed |
| 39941762 | Genetic Alterations in Patients with NF2-Related Schwannomatosis and Sporadic Vestibular Schwannomas. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/39941762 | PubMed |
| 39910685 | Current molecular understanding of central nervous system schwannomas. | Acta Neuropathol Commun | 2025 | https://conductscience.org/library/papers/39910685 | PubMed |
| 38372904 | Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma. | J Neurooncol | 2024 | https://conductscience.org/library/papers/38372904 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36944680
GET https://conductscience.org/api/papers/v1/36944680/references?page=2